Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Quoix

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
European Respiratory Review : an Official Journal of the European Respiratory Society|October 27, 2017
Lung segmentectomy: does it offer a real functional benefit over lobectomy?Anne Charloux, Elisabeth Quoix
La Revue Du Praticien|December 2, 2015
[MANAGEMENT OF LUNG CANCER IN ELDERLY]Charlotte Leduc, Elisabeth Quoix
Therapeutic Advances in Respiratory Disease|December 16, 2015
Is there a role for e-cigarettes in smoking cessation?Charlotte Leduc, Elisabeth Quoix
Journal of Thoracic Disease|October 30, 2018
Time to give a rest to cetuximab in the treatment of advanced non-small cell lung carcinoma?Elisabeth Quoix, Virginie Westeel
Oncoimmunology|August 31, 2012
TG4010: A therapeutic vaccine against MUC1 expressing tumorsJean-Marc Limacher, Elisabeth Quoix
La Revue Du Praticien|July 26, 2003
[Acute complications in lung cancer]Jean-Paul Sculier, Elisabeth Quoix
Bulletin Du Cancer|December 1, 2005
[Retrospective study of a series of 26 carcinomatous meningitis secondary to lung cancer]Valérie Hammerer, Gabrielle Pauli, Elisabeth Quoix
Lung Cancer (Amsterdam, Netherlands)|May 17, 2020
Ongoing challenges of using immunotherapy in special populations: Poor performance status patients, elderly patients, and people living with HIVValérie Gounant, Armelle Lavolé, Elisabeth Quoix
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 19, 2011
Tumor cell content for selection of molecular techniques for T790M EGFR mutation detection in non-small cell lung cancerNathalie Prim, Elisabeth Quoix, Michèle Beau-Faller
The European Respiratory Journal|July 2, 2015
Targeted therapies: detrimental treatment for nonsmall cell lung cancer without driver mutationsThierry Berghmans, Anne-Pascale Meert, Elisabeth Quoix
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
European Respiratory Review : an Official Journal of the European Respiratory Society|October 27, 2017
Lung segmentectomy: does it offer a real functional benefit over lobectomy?Anne Charloux, Elisabeth Quoix
La Revue Du Praticien|December 2, 2015
[MANAGEMENT OF LUNG CANCER IN ELDERLY]Charlotte Leduc, Elisabeth Quoix
Therapeutic Advances in Respiratory Disease|December 16, 2015
Is there a role for e-cigarettes in smoking cessation?Charlotte Leduc, Elisabeth Quoix
Journal of Thoracic Disease|October 30, 2018
Time to give a rest to cetuximab in the treatment of advanced non-small cell lung carcinoma?Elisabeth Quoix, Virginie Westeel
Oncoimmunology|August 31, 2012
TG4010: A therapeutic vaccine against MUC1 expressing tumorsJean-Marc Limacher, Elisabeth Quoix
La Revue Du Praticien|July 26, 2003
[Acute complications in lung cancer]Jean-Paul Sculier, Elisabeth Quoix
Bulletin Du Cancer|December 1, 2005
[Retrospective study of a series of 26 carcinomatous meningitis secondary to lung cancer]Valérie Hammerer, Gabrielle Pauli, Elisabeth Quoix
Lung Cancer (Amsterdam, Netherlands)|May 17, 2020
Ongoing challenges of using immunotherapy in special populations: Poor performance status patients, elderly patients, and people living with HIVValérie Gounant, Armelle Lavolé, Elisabeth Quoix
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 19, 2011
Tumor cell content for selection of molecular techniques for T790M EGFR mutation detection in non-small cell lung cancerNathalie Prim, Elisabeth Quoix, Michèle Beau-Faller
The European Respiratory Journal|July 2, 2015
Targeted therapies: detrimental treatment for nonsmall cell lung cancer without driver mutationsThierry Berghmans, Anne-Pascale Meert, Elisabeth Quoix
Pageof 12